May 2021 – The relationship between Accelera and CROss Alliance® started a decade ago and since then we have renewed our collaboration during the years.
Our specialisations, preclinical and early phase clinical development respectively, our shared values and expertise led us now to start a common project: to offer our clients an integrated solution aimed to streamline and optimize the clinical development process in the critical moment of the transition from pre-clinical to clinical set up.
We invite you to have a look to our informative material below in which we have listed the benefits of this package, product of the synergy of two healthy and stable companies.